A Study of IBI311 in Subjects With Active Thyroid Eye Disease
Clinical trial NCT05795621 · COMPLETED
Trial details
- NCT number
- NCT05795621
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-14
- Primary completion
- 2023-12-20
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.